Shlomi Raz, Eleusis CEO
Psychedelics startup Eleusis axes SPAC deal, but CEO confident its IV psilocybin therapy will enter clinic next month
Just two days after receiving approval from the UK’s drug regulator to start a Phase I trial, Eleusis and blank check partner Silver Spike canceled …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.